Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3063297 | Journal of Clinical Neuroscience | 2006 | 5 Pages |
Abstract
Eighty-one cases of chronic subdural haematomas (CSDH) admitted to the neurosurgical unit of the Royal Hobart Hospital, Tasmania, Australia, over a 5-year period were reviewed. The use of anticoagulant therapy as a causative agent in the development of CSDH was investigated. We suspected a high incidence of anticoagulant or anti-thrombotic therapy. We found that anticoagulant therapy was used by a significant percentage of CSDH patients. In the patient group presenting to our unit the risk of developing a CSDH was at least 42.5 times higher in warfarinised patients and also increased for patients on aspirin, although this risk could not be quantified.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Tilmann Rust, Nicole Kiemer, Albert Erasmus,